Lord, Abbett & Co
ARIA

Lord, Abbett & Co’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Lord, Abbett & Co’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,792,326
Closed -$22.3M – 973
2016
Q4 		$22.3M Sell
1,792,326
-750,292
-30% -$9.04M 0.07% 393
2016
Q3 		$34.8M Buy
+2,542,618
New +$25.5M 0.11% 305
2013
Q4 		– Sell
-175,734
Closed -$3.23M – 1129
2013
Q3 		$3.23M Sell
175,734
-13,599
-7% -$264K 0.01% 890
2013
Q2 		$3.31M Buy
+189,333
New +$3.36M 0.01% 879

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Lord, Abbett & Co's ARIA Position: Q1 2017 in Review

Lord, Abbett & Co sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 1,792,326 shares — an estimated $22.3M sold.

Lord, Abbett & Co first reported a position in ARIA in Q2 2013 and held it in 4 quarters. The position peaked at $34.8M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Lord, Abbett & Co reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Lord, Abbett & Co sold 1,792,326 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $22.3M.
  • Lord, Abbett & Co first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 4 quarters.
  • Lord, Abbett & Co's Ariad Pharmaceuticals Inc position peaked at $34.8M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Lord, Abbett & Co's 13F filing for Q1 2017, filed 15 May 2017.